Agios Pharmaceuticals, Inc. Share Price

Agios Pharmaceuticals, Inc. Share Price

NASDAQ: AGIO | Small Cap
$30.53
-$6.71 (-18.02%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Agios Pharmaceuticals, Inc. Stock Performance

Open
$30.90
Prev. Close
$37.24
Circuit Range
N/A
Day Range
$29.82 - $32.90
Year Range
$22.25 - $46.00
Volume
1,94,537
Average Traded
$30.69

Agios Pharmaceuticals, Inc. Share Price Today

As of 1 November 2026, Agios Pharmaceuticals, Inc.'s share price is $30.53. The stock opened at $30.90, compared to its previous close of $37.24. During today's trading session, Agios Pharmaceuticals, Inc.'s share price traded between $29.82 and $32.90, with an average price of $31.36. Over the past 52 weeks, the stock has recorded a high of $46.00 and a low of $22.25. In terms of performance, Agios Pharmaceuticals, Inc.'s share price has risen by 9.06% over the last six months and is down 29.43% on a year-on-year basis.

Agios Pharmaceuticals, Inc. Share Price Chart

Line chart of the Agios Pharmaceuticals, Inc. price trend over the selected period. The price fell overall, ranging from 29.81 to 31.05, ending at 30.53.
$29.82$32.90
L
Show Current Price
H

Agios Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.77B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-6.89
Revenue (TTM)
$54.03B
Return On Equity (TTM)
-40.09%
Profit Margin
-763.98%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
2.64%

Agios Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$12.88$19.97$20.75$44.75
Net Profit-$103.43-$108.04-$99.11-$100.70
Net Profit Margin-803.03%-541.01%-477.64%-225.03%
Income ChangeN/A-4.46%8.27%-1.60%

Agios Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$14.24$26.82$36.50$54.03
Net Profit-$231.80-$352.09$673.73-$412.78
Net Profit Margin-1627.81%-1312.79%1845.84%-763.98%
Income ChangeN/A-51.89%291.35%-161.27%

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Agios Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$33.55
$30.54
-8.37%
Sep 2026
$33.70
$33.33
-2.81%
Aug 2026
$30.13
$34.30
+14.41%
Jul 2026
$37.17
$29.98
-19.22%
Jun 2026
$29.04
$37.10
+26.23%
May 2026
$28.02
$29.39
+5.00%
Apr 2026
$33.89
$28.00
-17.25%
Mar 2026
$29.25
$33.83
+11.95%
Feb 2026
$27.88
$30.22
+10.05%
Jan 2026
$27.18
$27.46
+0.84%
Dec 2025
$28.54
$27.23
-6.71%
Nov 2025
$42.97
$29.19
-32.52%

AGIO Share Price FAQs